ProstaLund
5,7
SEK
0 %
Mindre end 1K følgere
PLUN
First North Stockholm
Medical Equipment & Services
Health Care
Overview
Finansielt overblik og estimater
Ownership
0%
-31,33%
-24,4%
-39,62%
-65,33%
-88,42%
-97,09%
-90,32%
-98,44%
ProstaLund operates in medical technology. Today, specialisation is mainly in the area of treatment of benign prostate enlargement (BPH). Through the company CoreTherm, heat treatment of benign prostate enlargement is offered, without the need for surgical operation. The vision is to offer both faster and more efficient solutions against traditional forms of infestation. The company was founded in 1991 and is operating globally, based in Lund.
Læs mereMarkedsværdi
20,66 mio. SEK
Aktieomsætning
575,95 SEK
Omsætning
13,73 mio.
EBIT %
-163,8 %
P/E
-
Udbytteafkast, %
-
Finanskalender
16.5
2025
Delårsrapport Q1'25
27.5
2025
Generalforsamling '25
21.8
2025
Delårsrapport Q2'25
Alle
Selskabsmeddelelser
Eksterne analyser
ViserAlle indholdstyper
Use of the Schelin Catheter® prior to water vapor thermal therapy shown to be cost-effective
ProstaLund AB - Year-end report 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools